Johnson & Johnson buy Traumtanz
Start price
26.03.20
/
50%
€113.30
Target price
20.04.20
€145.00
Performance (%)
23.88%
End price
20.04.20
€140.36
Summary
This prediction ended on 20.04.20 with a price of €140.36. The prediction had a final performance of 23.88%. Traumtanz has a follow-up prediction for Johnson & Johnson where he still thinks Johnson & Johnson is a Buy. Traumtanz has 50% into this predictionJohnson Johnson is a multinational company that focuses on the development, manufacturing, and marketing of a wide range of consumer health products, medical devices, and pharmaceuticals. The company was founded in 1886 and is headquartered in New Jersey, USA. It operates in more than 60 countries and has a diverse portfolio of popular brands including Band-Aid, Tylenol, and Neutrogena. As of 2021, Johnson Johnson has a market capitalization of over $435 billion and is listed on the New York Stock Exchange under the symbol JNJ.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Johnson & Johnson | -1.269% | -1.269% | -6.730% | 1.093% |
| iShares Core DAX® | -1.670% | -1.001% | 10.864% | 12.563% |
| iShares Nasdaq 100 | -4.184% | -1.145% | 37.458% | 41.078% |
| iShares Nikkei 225® | -4.967% | -5.783% | 18.828% | 0.655% |
| iShares S&P 500 | -2.834% | -0.572% | 25.875% | 39.960% |
According to Traumtanz what are the pros and cons of Johnson & Johnson for the foreseeable future?
Pros
High dividend yield expected
positive Cash Flow expected
Good rating
Standard Investments for future growth
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
Valuable balance sheet
ROE higher than 10% per year
Capable Management
Good culture
Innovative
Some uniques
Growths faster than the competition
Sustainability is important
Stable Large shareholder and/or long term investor
Medium risks for its business
Top 10 in its market
Small cyclical dependencies
Known brand
Future proof or reliable business model
Normal challenges to pay loans and raise capital
Differentiated customer and product portfolio
Cons
Comments by Traumtanz for this prediction
In the thread Johnson & Johnson diskutieren
Buy mit Kursziel 130,0
Kursziel geändert auf 135,0
Kursziel geändert auf 140,0
Kursziel geändert auf 145,0
In the thread Trading Johnson & Johnson
Buy beendet
Current prediction by Traumtanz for Johnson & Johnson
Johnson & Johnson
Start price
Target price
Perf. (%)
€157.90
16.08.23
16.08.23
€160.00
16.08.24
16.08.24
-11.43%
12:37
12:37
High dividend yield expected
positive Cash Flow expected
Good rating
Standard Investments for future growth
Stopped prediction by Traumtanz for Johnson & Johnson
Johnson & Johnson
Start price
Target price
Perf. (%)
€152.60
24.07.23
24.07.23
€155.00
24.07.24
24.07.24
3.47%
16.08.23
16.08.23
High dividend yield expected
positive Cash Flow expected
Good rating
Standard Investments for future growth
Johnson & Johnson
Start price
Target price
Perf. (%)
€145.40
11.07.23
11.07.23
€155.00
11.07.24
11.07.24
4.95%
24.07.23
24.07.23
High dividend yield expected
positive Cash Flow expected
Good rating
Standard Investments for future growth
Johnson & Johnson
Start price
Target price
Perf. (%)
€171.94
26.09.22
26.09.22
€150.00
26.09.23
26.09.23
-15.44%
11.07.23
11.07.23
High dividend yield expected
positive Cash Flow expected
Good rating
Standard Investments for future growth
Johnson & Johnson
Start price
Target price
Perf. (%)
€123.90
21.11.20
21.11.20
€140.00
2.62%
10.12.20
10.12.20
High dividend yield expected
positive Cash Flow expected
Good rating
Standard Investments for future growth
Johnson & Johnson
Start price
Target price
Perf. (%)
€140.64
29.04.20
29.04.20
€155.00
30.04.20
30.04.20
-2.23%
30.04.20
30.04.20
High dividend yield expected
positive Cash Flow expected
Good rating
Standard Investments for future growth
Johnson & Johnson
Start price
Target price
Perf. (%)
€121.12
10.03.20
10.03.20
€130.00
20.03.20
20.03.20
-4.23%
20.03.20
20.03.20
High dividend yield expected
positive Cash Flow expected
Good rating
Standard Investments for future growth
Johnson & Johnson
Start price
Target price
Perf. (%)
€119.51
17.07.19
17.07.19
€135.30
19.07.19
19.07.19
-1.65%
19.07.19
19.07.19
High dividend yield expected
positive Cash Flow expected
Good rating
Standard Investments for future growth
Johnson & Johnson
Start price
Target price
Perf. (%)
€119.52
17.07.19
17.07.19
€135.30
17.07.19
17.07.19
0.00%
17.07.19
17.07.19
High dividend yield expected
positive Cash Flow expected
Good rating
Standard Investments for future growth
Johnson & Johnson
Start price
Target price
Perf. (%)
€131.89
11.12.18
11.12.18
€135.30
17.12.18
17.12.18
-11.67%
17.12.18
17.12.18
High dividend yield expected
positive Cash Flow expected
Good rating
Standard Investments for future growth
Johnson & Johnson
Start price
Target price
Perf. (%)
€118.87
25.07.17
25.07.17
€135.30
23.03.18
23.03.18
-2.81%
23.03.18
23.03.18
High dividend yield expected
positive Cash Flow expected
Good rating
Standard Investments for future growth
Johnson & Johnson
Start price
Target price
Perf. (%)
€102.29
28.01.17
28.01.17
€135.30
24.07.17
24.07.17
19.63%
24.07.17
24.07.17
High dividend yield expected
positive Cash Flow expected
Good rating
Standard Investments for future growth